Nolan King Quality of Life Trial
AflacST1502: A Phase II Study of Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors
Dr. Cash’s trial provides a potentially life-extending, tumor-stabilizing treatment option for children with no curative options remaining. By combining a variety of oral medications, including immunotherapy and low dose chemotherapy, patients are able to spend most of their time outside the hospital because of simple drug administration and fewer side effects than typical treatment regimens.
This Project By The Numbers
Years Active2 years
InstitutionEmory University, Children’s Healthcare of Atlanta